Having wrapped up the first phase of reverse circulation (RC) drilling, Pantoro Ltd has fielded positive gold results at the Hinemoa Fault on the Polar Bear peninsula, a key target within its Norseman Gold Project in Western Australia.
Checkpoint Therapeutics (NASDAQ:CKPT) shares added more than 60% after it was revealed the immunology and targeted oncology firm will be acquired by Sun Pharmaceutical Industries.
Under the agreement, Sun Pharma will acquire Checkpoint for $4.10 per share in cash, representing up to $355 million in upfront payments.
Redfin Corp (NASDAQ:RDFN) shares surged more than 70% after the fintech company annoucned it is being acquired by Rocket Companies Inc (NYSE:RKT) in a transaction valued at $1.75 billion.
In the all-stock transaction, Redfin will be acquired for $12.50 per share.
Diversified Energy Company PLC (LSE:DEC, NYSE:DEC) has struck a new partnership with FuelCell Energy and TESIAC to develop 360 megawatts of power generation capacity for data centres in Virginia, West Virginia, and Kentucky.
The collaboration will use natural gas and coal mine methane to provide off-grid power, reducing dependence on traditional grid infrastructure in the development of data centres.
North Bay Resources Inc. (OTC:NBRI) reported high-grade copper, silver, and vanadium mineralization from its February 2025 exploration program at the Copper Island project in British Columbia.
Rock sampling from eight outcrops at the Pomeroy 1-3, Beaver, and Copper Bell zones returned assay values as high as 5.69% copper, 1 ounce per ton silver, and 0.22% vanadium.
OKYO Pharma Ltd (NASDAQ:OKYO) announced that it has filed a Fast Track designation application with the US Food and Drug Administration (FDA) for urcosimod, for the treatment of neuropathic corneal pain (NCP).
The FDA's Fast Track designation is intended to accelerate the development and review of treatments for serious conditions with unmet medical needs, potentially expediting urcosimod's path to market if it is granted.
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) reported mining 89 Bitcoin (BTC) in February, bringing its total BTC holdings to 2,620, valued at $220 million as of February 28.
The company maintained an average mining capacity of 5.6 exahash per second (EH/s), reaching a peak BTC-only hashrate of 6.2 EH/s.
GoviEx Uranium Inc (TSX-V:GXU, OTCQX:GVXXF) announced that it has filed a feasibility study (FS) for its Muntanga uranium project in Zambia, marking a key step toward advancing one of the few near-term uranium projects positioned to address rising nuclear fuel demand.
The project has an after-tax net present value (NPV) of $243 million and an internal rate of return (IRR) of 20.8%, with operating costs estimated at $32.20 per pound of U3O8 (uranium), the FS showed.
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) shares climbed 5% in early trading after securing a major deal to expand its Xenon MRI technology into pharmaceutical research.
A top global pharmaceutical company has selected Polarean’s imaging services for a multi-centre clinical trial, which will evaluate an investigational lung treatment.
Shares in Orosur Mining Inc (AIM:OMI, TSX-V:OMI) jumped as much as 8% in early trading on Monday after the company released promising new drilling results from its flagship Anzá gold project in Colombia.
Investors were encouraged by fresh assay results from the Pepas prospect, which confirmed substantial gold mineralisation over thick intervals. One standout drill hole returned 62.5 metres at 5.4 grams per tonne of gold, while another intercepted nearly 80 metres of mineralisation.
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has successfully expanded its new imaging service model by securing a deal to expand its Xenon MRI imaging platform into pharmaceutical research, marking a big step forward for the company.
An unnamed leading global pharmaceutical firm has chosen Polarean’s technology for a multicentre clinical trial, testing an investigational lung treatment. The trial will use Xenon MRI to assess how the new therapy affects lung function, providing detailed insights into ventilation and gas exchange.
Resolution Minerals Ltd has turned its attention to antimony with gold and copper upside after entering into a Binding Agreement to acquire three highly prospective exploration projects in New South Wales and Queensland, covering a total of approximately 194 square kilometres.
Resolution’s binding term sheet is with Devil Prospecting Pty Ltd and 1205 Pty Ltd to acquire 100% of their issued share capital and exploration licences EL 9730, EL 9719, EL 9720, and EPM 29111.